Does Rallies show 13F holders for WGS?

Yes. Rallies tracks hedge fund and 13F ownership data for WGS, including fund names, share counts, latest tracked quarter, and position changes when available.

Is WGS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for WGS. It does not provide personalized investment advice.

WGS (GeneDx Holdings Corp. Class A Common Stock) Stock Analysis - Hedge Fund Holdings

GeneDx Holdings Corp. Class A Common Stock (WGS) is a publicly traded Healthcare sector company. As of May 20, 2026, WGS trades at $44.09 with a market cap of $1.27B and a P/E ratio of -59.93. WGS moved +6.22% today. Year to date, WGS is -65.98%; over the trailing twelve months it is -37.97%. Its 52-week range spans $32.21 to $170.87. Analyst consensus is strong buy with an average price target of $91.25. Rallies surfaces WGS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns WGS stock?

Hedge funds tracked by Rallies that own WGS include Corvex Management, Polen Capital, Pentwater Capital, Centerbook Partners, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for GeneDx Holdings Corp. Class A Common Stock.

WGS Key Metrics

Key financial metrics for WGS
Metric	Value
Price	$44.09
Market Cap	$1.27B
P/E Ratio	-59.93
EPS	$-0.73
Dividend Yield	0.00%
52-Week High	$170.87
52-Week Low	$32.21
Volume	999.66K
Avg Volume	0
Revenue (TTM)	$427.54M
Net Income	$-21.02M
Gross Margin	69.74%

Top Hedge Funds Holding WGS

Corvex Management holds 3.23M shares of WGS, changed +5.54% as of Mar 31, 2026.
Polen Capital holds 77.42K shares of WGS, changed +29.33% as of Mar 31, 2026.
Pentwater Capital holds 50.00K shares of WGS, changed -88.24% as of Dec 31, 2025.
Centerbook Partners holds 17.89K shares of WGS, changed +0.00% as of Dec 31, 2025.
Farallon Capital holds 5.00K shares of WGS, changed -92.86% as of Mar 31, 2026.

Latest WGS News

GeneDx Cuts 2026 Revenue Outlook to $475–490M After 34% Volume Surge — May 4, 2026
GeneDx Forecasts Q1 $113M Revenue and Deepens 2026 Loss Forecast to $1.38 EPS — May 1, 2026
GeneDx Expands NPC Testing Access with Zevra via ExomeDx and Infinity Dataset — Mar 10, 2026
Analysts’ $156.67 Mean Target Implies 77.8% Upside for GeneDx — Mar 9, 2026
GeneDx Holdings Falls 25% in Four Weeks While EPS Estimates Rise 29.3% — Mar 3, 2026

Recent WGS Insider Trades

Meister Keith A. bought 27.41K (~$1.05M) on May 15, 2026.
Meister Keith A. bought 18.86K (~$751.39K) on May 15, 2026.
Meister Keith A. bought 88.11K (~$3.44M) on May 14, 2026.

WGS Analyst Consensus

8 analysts cover WGS: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $91.25.

Common questions about WGS

Who owns WGS stock?: Hedge funds tracked by Rallies that own WGS include Corvex Management, Polen Capital, Pentwater Capital, Centerbook Partners, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for GeneDx Holdings Corp. Class A Common Stock.
Does Rallies show 13F holders for WGS?: Yes. Rallies tracks hedge fund and 13F ownership data for WGS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is WGS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for WGS. It does not provide personalized investment advice.